Enrique Poradosu - 27 Mar 2023 Form 4 Insider Report for Nuvectis Pharma, Inc. (NVCT)

Role
Chief Science & Business Off
Signature
/s/ Enrique Poradosu
Issuer symbol
NVCT
Transactions as of
27 Mar 2023
Net transactions value
+$5,775
Form type
4
Filing time
28 Mar 2023, 08:30:14 UTC
Previous filing
13 Jan 2023
Next filing
05 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCT Common Stock Purchase $5,775 +500 +0.04% $11.55 1,373,819 27 Mar 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 48,399 shares of restricted stock and 175,000 restricted stock units.